Skip to main content
Erschienen in: Pathology & Oncology Research 3/2010

01.09.2010

Comparison of Beta-catenin with TGF-beta1, HIF-1alpha and Patients’ Disease-free Survival in Human Colorectal Cancer

verfasst von: Andrzej Wincewicz, Mariusz Koda, Stanislaw Sulkowski, Luiza Kanczuga-Koda, Mariola Sulkowska

Erschienen in: Pathology & Oncology Research | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Beta-catenin accumulation is suppressed by TGF-beta1 (transforming growth factor beta1) in intestinal epithelium suggesting negative feedback between these two factors. Besides that, beta-catenin interacts with HIF-1alpha (hypoxia-inducible factor-1alpha) at the promoter region of HIF-1 target genes. Our study was aimed at comparison of beta-catenin with HIF-1alpha, TGF-beta1, Ki67 and survival of sporadic colorectal cancer patients. Expressions of beta-catenin, TGF-beta1, HIF-1alpha, Ki67 were evaluated in triads of specimens of each primary tumor of 72 sporadic colorectal cancers with immunohistochemistry due to limited availability of tissue material. Disease-free survival was analyzed in case of all 100 beta-catenin stained tumors, in 85 cancers stained for HIF-1 and in 72 neoplasms with TGFbeta1 staining. Beta-catenin, TGF-beta1 and HIF-1alpha accumulated in 72 colorectal cancer cells. Beta-catenin correlated both with HIF-1alpha and TGF-beta1 in all colorectal cancers (p < 0.009, r = 0.307 and p = 0.003, r = 0.342, respectively) and in subgroups of different clinico-pathological profile. Beta-catenin failed to correlate with Ki67. In case of beta-catenin, TGF-beta1 and HIF-1alpha, disease-free survival curves failed to show any statistically significant differences between groups of marker negative tumors, cancers with low expression and neoplasms with higher protein expression. Positive correlations between beta-catenin and TGF-beta1 may indicate ineffective attempts of TGF-beta1 to reduce intracellular level of beta-catenin in colorectal cancer. Associations between beta-catenin and HIF-1alpha reflect previously detected interactions between HIF-1alpha with beta-catenin and are confirmative for presence of such reactions in human colorectal cancer.
Literatur
1.
Zurück zum Zitat Wong NA, Pignatelli M (2002) Beta-catenin-a linchpin in colorectal carcinogenesis? Am J Pathol 160:389–401PubMed Wong NA, Pignatelli M (2002) Beta-catenin-a linchpin in colorectal carcinogenesis? Am J Pathol 160:389–401PubMed
2.
Zurück zum Zitat Lüchtenborg M, Weijenberg MP, Wark PA, Saritas AM, Roemen GM, van Muijen GN, de Bruïne AP, van den Brandt PA, de Goeij AF (2005) Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study. BMC Cancer 5:160CrossRefPubMed Lüchtenborg M, Weijenberg MP, Wark PA, Saritas AM, Roemen GM, van Muijen GN, de Bruïne AP, van den Brandt PA, de Goeij AF (2005) Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study. BMC Cancer 5:160CrossRefPubMed
3.
Zurück zum Zitat Sulkowska M, Wincewicz A, Sulkowski S, Koda M, Kanczuga-Koda L (2009) Relations of TGF-beta1 with HIF-1alpha, GLUT-1 and longer survival of colorectal cancer patients. Pathology Jan 13:1–7. [Epub ahead of print] Sulkowska M, Wincewicz A, Sulkowski S, Koda M, Kanczuga-Koda L (2009) Relations of TGF-beta1 with HIF-1alpha, GLUT-1 and longer survival of colorectal cancer patients. Pathology Jan 13:1–7. [Epub ahead of print]
4.
Zurück zum Zitat Xu J, Attisano L (2000) Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 97:4820–4825CrossRefPubMed Xu J, Attisano L (2000) Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 97:4820–4825CrossRefPubMed
5.
Zurück zum Zitat Li F, Cao Y, Townsend CM Jr, Ko TC (2005) TGF-beta signaling in colon cancer cells. World J Surg 29:306–311CrossRefPubMed Li F, Cao Y, Townsend CM Jr, Ko TC (2005) TGF-beta signaling in colon cancer cells. World J Surg 29:306–311CrossRefPubMed
6.
Zurück zum Zitat Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A (2007) TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. BMC Cancer 7:156CrossRefPubMed Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A (2007) TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. BMC Cancer 7:156CrossRefPubMed
7.
Zurück zum Zitat Giles RH, Lolkema MP, Snijckers CM, Belderbos M, van der Groep P, Mans DA, van Beest M, van Noort M, Goldschmeding R, van Diest PJ, Clevers H, Voest EE (2006) Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. Oncogene 25:3065–3070CrossRefPubMed Giles RH, Lolkema MP, Snijckers CM, Belderbos M, van der Groep P, Mans DA, van Beest M, van Noort M, Goldschmeding R, van Diest PJ, Clevers H, Voest EE (2006) Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. Oncogene 25:3065–3070CrossRefPubMed
8.
Zurück zum Zitat de la Roche M, Worm J, Bienz M (2008) The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells. BMC Cancer 8:199CrossRefPubMed de la Roche M, Worm J, Bienz M (2008) The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells. BMC Cancer 8:199CrossRefPubMed
9.
Zurück zum Zitat Lim JH, Chun YS, Park JW (2008) Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin. Cancer Res 68:5177–5184CrossRefPubMed Lim JH, Chun YS, Park JW (2008) Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin. Cancer Res 68:5177–5184CrossRefPubMed
10.
Zurück zum Zitat Li LN, Zhang HD, Yuan SJ, Tian ZY, Wang L, Sun ZX (2007) Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway. Int J Cancer 121:1360–1365CrossRefPubMed Li LN, Zhang HD, Yuan SJ, Tian ZY, Wang L, Sun ZX (2007) Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway. Int J Cancer 121:1360–1365CrossRefPubMed
11.
Zurück zum Zitat Kaidi A, Williams AC, Paraskeva C (2007) Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 9:210–217CrossRefPubMed Kaidi A, Williams AC, Paraskeva C (2007) Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 9:210–217CrossRefPubMed
12.
Zurück zum Zitat Wincewicz A, Sulkowska M, Koda M, Sulkowski S (2007) Cumulative expression of HIF-1-alpha, Bax, Bcl-xL and P53 in human colorectal cancer. Pathology 39:334–338CrossRefPubMed Wincewicz A, Sulkowska M, Koda M, Sulkowski S (2007) Cumulative expression of HIF-1-alpha, Bax, Bcl-xL and P53 in human colorectal cancer. Pathology 39:334–338CrossRefPubMed
13.
Zurück zum Zitat Wincewicz A, Sulkowska M, Koda M, Sulkowski S (2007) Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer. Pathol Oncol Res 13:15–20CrossRefPubMed Wincewicz A, Sulkowska M, Koda M, Sulkowski S (2007) Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer. Pathol Oncol Res 13:15–20CrossRefPubMed
14.
Zurück zum Zitat Wang H, Promkan M, Liu G, Chakrabarty S (2008) Switch of transforming growth factor beta function from tumor suppression to stimulation in adenomatous polyposis coli (APC) knocked-down human colon carcinoma cells. Cancer Lett 272:253–259CrossRefPubMed Wang H, Promkan M, Liu G, Chakrabarty S (2008) Switch of transforming growth factor beta function from tumor suppression to stimulation in adenomatous polyposis coli (APC) knocked-down human colon carcinoma cells. Cancer Lett 272:253–259CrossRefPubMed
15.
Zurück zum Zitat Wang H, Rajan S, Liu G, Chakrabarty S (2008) Transforming growth factor beta suppresses beta-catenin/Wnt signaling and stimulates an adhesion response in human colon carcinoma cells in a Smad4/DPC4 independent manner. Cancer Lett 264:281–287CrossRefPubMed Wang H, Rajan S, Liu G, Chakrabarty S (2008) Transforming growth factor beta suppresses beta-catenin/Wnt signaling and stimulates an adhesion response in human colon carcinoma cells in a Smad4/DPC4 independent manner. Cancer Lett 264:281–287CrossRefPubMed
16.
Zurück zum Zitat Lambie DL, Brown IS (2008) Multinucleate epithelial change in colorectal hyperplastic polyps: a review of 27 cases. J Clin Pathol 61:611–614CrossRefPubMed Lambie DL, Brown IS (2008) Multinucleate epithelial change in colorectal hyperplastic polyps: a review of 27 cases. J Clin Pathol 61:611–614CrossRefPubMed
17.
Zurück zum Zitat Settakorn J, Kaewpila N, Burns GF, Leong AS (2005) FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma. J Clin Pathol 58:1249–1254CrossRefPubMed Settakorn J, Kaewpila N, Burns GF, Leong AS (2005) FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma. J Clin Pathol 58:1249–1254CrossRefPubMed
18.
Zurück zum Zitat Pirinen RT, Hirvikoski P, Johansson RT, Hollmén S, Kosma VM (2001) Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol 54:391–395CrossRefPubMed Pirinen RT, Hirvikoski P, Johansson RT, Hollmén S, Kosma VM (2001) Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol 54:391–395CrossRefPubMed
19.
Zurück zum Zitat Wong SC, Chan AT, Chan JK, Lo YM (2006) Nuclear beta-catenin and Ki-67 expression in choriocarcinoma and its pre-malignant form. J Clin Pathol 59:387–392CrossRefPubMed Wong SC, Chan AT, Chan JK, Lo YM (2006) Nuclear beta-catenin and Ki-67 expression in choriocarcinoma and its pre-malignant form. J Clin Pathol 59:387–392CrossRefPubMed
20.
Zurück zum Zitat Takeda K, Kinoshita I, Shimizu Y, Ohba Y, Itoh T, Matsuno Y, Shichinohe T, Dosaka-Akita H (2008) Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-catenin in colorectal tumors. BMC Cancer 8:328CrossRefPubMed Takeda K, Kinoshita I, Shimizu Y, Ohba Y, Itoh T, Matsuno Y, Shichinohe T, Dosaka-Akita H (2008) Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-catenin in colorectal tumors. BMC Cancer 8:328CrossRefPubMed
21.
Zurück zum Zitat Tien YW, Jeng YM, Hu RH, Chang KJ, Hsu SM, Lee PH (2004) Intravasation-related metastatic factors in colorectal cancer. Tumour Biol 25:48–55CrossRefPubMed Tien YW, Jeng YM, Hu RH, Chang KJ, Hsu SM, Lee PH (2004) Intravasation-related metastatic factors in colorectal cancer. Tumour Biol 25:48–55CrossRefPubMed
22.
Zurück zum Zitat Pećina-Slaus N, Niku Eva-Martić T, Beros V et al (2007) Genetic alterations of E-cadherin and beta-catenin in germinoma and teratoma: report of two central nervous system cases. Pathol Oncol Res 13:370–374CrossRefPubMed Pećina-Slaus N, Niku Eva-Martić T, Beros V et al (2007) Genetic alterations of E-cadherin and beta-catenin in germinoma and teratoma: report of two central nervous system cases. Pathol Oncol Res 13:370–374CrossRefPubMed
23.
Zurück zum Zitat Kabukcuoglu F, Kabukcuoglu Y, Tanik C et al (2008) Breast carcinoma metastasis in recurrent myxoid liposarcoma. Pathol Oncol Res Kabukcuoglu F, Kabukcuoglu Y, Tanik C et al (2008) Breast carcinoma metastasis in recurrent myxoid liposarcoma. Pathol Oncol Res
24.
Zurück zum Zitat Horst D, Kriegl L, Engel J et al (2009) CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer. Eur J Cancer Horst D, Kriegl L, Engel J et al (2009) CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer. Eur J Cancer
25.
Zurück zum Zitat Horst D, Reu S, Kriegl L et al (2009) The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer. Cancer 115:2063–2070CrossRefPubMed Horst D, Reu S, Kriegl L et al (2009) The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer. Cancer 115:2063–2070CrossRefPubMed
26.
Zurück zum Zitat Bondi J, Bukholm G, Nesland JM, Bakka A, Bukholm IR (2006) An increase in the number of adhesion proteins with altered expression is associated with an increased risk of cancer death for colon carcinoma patients. Int J Colorectal Dis 21:231–237CrossRefPubMed Bondi J, Bukholm G, Nesland JM, Bakka A, Bukholm IR (2006) An increase in the number of adhesion proteins with altered expression is associated with an increased risk of cancer death for colon carcinoma patients. Int J Colorectal Dis 21:231–237CrossRefPubMed
27.
Zurück zum Zitat Canavese G, Bernardi A, Candelaresi G, Lovadina P, Amerio S, Rossetti V, Rabagliati C, Berardengo E (2007) Expression of the E-cadherin-catenins complex in sentinel node is related to tumor morphology but not to spread to nonsentinel nodes. Pathol Res Pract 203:517–523CrossRefPubMed Canavese G, Bernardi A, Candelaresi G, Lovadina P, Amerio S, Rossetti V, Rabagliati C, Berardengo E (2007) Expression of the E-cadherin-catenins complex in sentinel node is related to tumor morphology but not to spread to nonsentinel nodes. Pathol Res Pract 203:517–523CrossRefPubMed
28.
Zurück zum Zitat Stewart CJ, Crook ML, Leung YC, Platten M (2009) Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands. Mod Pathol, Mar 6. [Epub ahead of print] Stewart CJ, Crook ML, Leung YC, Platten M (2009) Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands. Mod Pathol, Mar 6. [Epub ahead of print]
29.
Zurück zum Zitat Nagayama S, Yamada E, Kohno Y, Aoyama T, Fukukawa C, Kubo H, Watanabe G, Katagiri T, Nakamura Y, Sakai Y, Toguchida J (2009) Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumors. Cancer Sci 100:405–412CrossRefPubMed Nagayama S, Yamada E, Kohno Y, Aoyama T, Fukukawa C, Kubo H, Watanabe G, Katagiri T, Nakamura Y, Sakai Y, Toguchida J (2009) Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumors. Cancer Sci 100:405–412CrossRefPubMed
30.
Zurück zum Zitat Mees ST, Mennigen R, Spieker T, Rijcken E, Senninger N, Haier J, Bruewer M (2009) Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: upregulation of claudin-1, claudin-3, claudin-4, and beta-catenin. Int J Colorectal Dis 24:361–368CrossRefPubMed Mees ST, Mennigen R, Spieker T, Rijcken E, Senninger N, Haier J, Bruewer M (2009) Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: upregulation of claudin-1, claudin-3, claudin-4, and beta-catenin. Int J Colorectal Dis 24:361–368CrossRefPubMed
Metadaten
Titel
Comparison of Beta-catenin with TGF-beta1, HIF-1alpha and Patients’ Disease-free Survival in Human Colorectal Cancer
verfasst von
Andrzej Wincewicz
Mariusz Koda
Stanislaw Sulkowski
Luiza Kanczuga-Koda
Mariola Sulkowska
Publikationsdatum
01.09.2010
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 3/2010
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-009-9217-2

Weitere Artikel der Ausgabe 3/2010

Pathology & Oncology Research 3/2010 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.